Encompass Health (EHC) Q2 2026 earnings — TrendMatrix coverage

Reported EPS

$1.55

Estimate

$1.48

Surprise

+4.8%

Score today

5.7/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Encompass Health (EHC) beat the $1.48 estimate with diluted EPS of $1.55 — a clear 4.8% upside surprise.

TrendMatrix currently rates EHC Hold at 5.7/10; no pre/post engine snapshot brackets this report.

4 of the last 4 quarters beat the estimate; this quarter's +4.8% surprise compares with a +6.8% four-quarter average. Next scheduled report: 2026-10-28.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$122.59

Price target

$128.91

Stop

$117.97

Upside to target

+5.2%

Reward-to-risk

1.0:1

Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry

Medical Care Facilities

Market cap

$12.09B

P/E (fwd)

18.4

P/E (ttm)

20.2

52-week range

$92.77–$127.99

Off 52-week high

4.2%

RSI (14)

46

Volume vs avg

0.85×

Score today

5.7/10